S&P 500   3,837.75 (+1.84%)
DOW   31,465.24 (+1.75%)
QQQ   308.52 (+1.45%)
AAPL   121.10 (+0.81%)
MSFT   232.77 (+2.66%)
FB   263.78 (+2.38%)
GOOGL   2,092.13 (+2.86%)
TSLA   596.24 (-4.06%)
AMZN   2,993.62 (+0.54%)
NVDA   498.05 (+0.65%)
BABA   234.71 (+1.83%)
CGC   30.90 (-0.35%)
GE   13.50 (-0.52%)
MU   88.89 (+5.41%)
NIO   37.45 (-4.66%)
AMD   78.59 (+1.08%)
T   29.60 (+2.35%)
F   12.20 (+2.26%)
ACB   9.52 (-3.05%)
DIS   189.64 (+0.86%)
BA   221.30 (-1.52%)
NFLX   512.75 (+0.29%)
BAC   36.82 (+0.88%)
S&P 500   3,837.75 (+1.84%)
DOW   31,465.24 (+1.75%)
QQQ   308.52 (+1.45%)
AAPL   121.10 (+0.81%)
MSFT   232.77 (+2.66%)
FB   263.78 (+2.38%)
GOOGL   2,092.13 (+2.86%)
TSLA   596.24 (-4.06%)
AMZN   2,993.62 (+0.54%)
NVDA   498.05 (+0.65%)
BABA   234.71 (+1.83%)
CGC   30.90 (-0.35%)
GE   13.50 (-0.52%)
MU   88.89 (+5.41%)
NIO   37.45 (-4.66%)
AMD   78.59 (+1.08%)
T   29.60 (+2.35%)
F   12.20 (+2.26%)
ACB   9.52 (-3.05%)
DIS   189.64 (+0.86%)
BA   221.30 (-1.52%)
NFLX   512.75 (+0.29%)
BAC   36.82 (+0.88%)
S&P 500   3,837.75 (+1.84%)
DOW   31,465.24 (+1.75%)
QQQ   308.52 (+1.45%)
AAPL   121.10 (+0.81%)
MSFT   232.77 (+2.66%)
FB   263.78 (+2.38%)
GOOGL   2,092.13 (+2.86%)
TSLA   596.24 (-4.06%)
AMZN   2,993.62 (+0.54%)
NVDA   498.05 (+0.65%)
BABA   234.71 (+1.83%)
CGC   30.90 (-0.35%)
GE   13.50 (-0.52%)
MU   88.89 (+5.41%)
NIO   37.45 (-4.66%)
AMD   78.59 (+1.08%)
T   29.60 (+2.35%)
F   12.20 (+2.26%)
ACB   9.52 (-3.05%)
DIS   189.64 (+0.86%)
BA   221.30 (-1.52%)
NFLX   512.75 (+0.29%)
BAC   36.82 (+0.88%)
S&P 500   3,837.75 (+1.84%)
DOW   31,465.24 (+1.75%)
QQQ   308.52 (+1.45%)
AAPL   121.10 (+0.81%)
MSFT   232.77 (+2.66%)
FB   263.78 (+2.38%)
GOOGL   2,092.13 (+2.86%)
TSLA   596.24 (-4.06%)
AMZN   2,993.62 (+0.54%)
NVDA   498.05 (+0.65%)
BABA   234.71 (+1.83%)
CGC   30.90 (-0.35%)
GE   13.50 (-0.52%)
MU   88.89 (+5.41%)
NIO   37.45 (-4.66%)
AMD   78.59 (+1.08%)
T   29.60 (+2.35%)
F   12.20 (+2.26%)
ACB   9.52 (-3.05%)
DIS   189.64 (+0.86%)
BA   221.30 (-1.52%)
NFLX   512.75 (+0.29%)
BAC   36.82 (+0.88%)
Log in
NASDAQ:MGEN

Miragen Therapeutics News Headlines

$15.50
-0.28 (-1.77 %)
(As of 03/4/2021 12:00 AM ET)
Add
Compare
Today's Range
$14.65
Now: $15.50
$16.00
50-Day Range
$16.44
MA: $20.15
$24.93
52-Week Range
$4.66
Now: $15.50
$34.05
Volume47,701 shs
Average Volume134,027 shs
Market Capitalization$60.57 million
P/E RatioN/A
Dividend YieldN/A
Beta1.66

Headlines

Miragen Therapeutics (NASDAQ MGEN) News Headlines Today

Source:
SourceHeadline
Miragen Therapeutics (NASDAQ:MGEN) Shares Pass Below 50 Day Moving Average of $19.82Miragen Therapeutics (NASDAQ:MGEN) Shares Pass Below 50 Day Moving Average of $19.82
americanbankingnews.com - February 16 at 5:08 AM
miRagen Therapeutics Announces Company Name Change to Viridian Therapeutics and New Executive Appointments, Including Expansion of Leadership TeammiRagen Therapeutics Announces Company Name Change to Viridian Therapeutics and New Executive Appointments, Including Expansion of Leadership Team
finance.yahoo.com - January 19 at 4:34 PM
miRagen Enters into License Agreement with Xencor for use of Xtend™ Antibody Technology for Investigational Antibodies to Treat Thyroid Eye DiseasemiRagen Enters into License Agreement with Xencor for use of Xtend™ Antibody Technology for Investigational Antibodies to Treat Thyroid Eye Disease
finance.yahoo.com - December 17 at 9:47 AM
Miragen Therapeutics EPS beats by $0.03Miragen Therapeutics EPS beats by $0.03
seekingalpha.com - November 10 at 6:18 PM
miRagen Reports Third Quarter 2020 Financial Results and Provides Corporate UpdatesmiRagen Reports Third Quarter 2020 Financial Results and Provides Corporate Updates
finance.yahoo.com - November 10 at 6:18 PM
Iovance (IOVA) Q3 Earnings Beat Estimates, Pipeline in FocusIovance (IOVA) Q3 Earnings Beat Estimates, Pipeline in Focus
finance.yahoo.com - November 9 at 9:46 AM
Miragen Therapeutics IncMiragen Therapeutics Inc
bloomberg.com - November 1 at 12:02 AM
MiRagen Therapeutics shares skyrocket 156% on Viridian acquisition, inks PIPE deal for $91MMiRagen Therapeutics shares skyrocket 156% on Viridian acquisition, inks PIPE deal for $91M
seekingalpha.com - October 30 at 1:51 PM
Looking Into Miragen Therapeutics's Return On Capital EmployedLooking Into Miragen Therapeutics's Return On Capital Employed
finance.yahoo.com - October 29 at 8:59 AM
Looking Into Miragen Therapeuticss Return On Capital EmployedLooking Into Miragen Therapeutics's Return On Capital Employed
benzinga.com - October 28 at 1:30 PM
Why Miragens Stock Is Trading Higher TodayWhy Miragen's Stock Is Trading Higher Today
benzinga.com - October 28 at 11:04 AM
MiRagen Therapeutics (MGEN) shares skyrocket 156% on Viridian acquisition, inks PIPE deal for $91MMiRagen Therapeutics (MGEN) shares skyrocket 156% on Viridian acquisition, inks PIPE deal for $91M
seekingalpha.com - October 28 at 7:47 AM
miRagen Therapeutics, Inc. Announces Acquisition of Viridian Therapeutics, Inc.miRagen Therapeutics, Inc. Announces Acquisition of Viridian Therapeutics, Inc.
finance.yahoo.com - October 28 at 7:47 AM
miRagen Announces Internal Review of Preliminary Topline Data for the Phase 2 SOLAR Clinical Trial of Cobomarsen in Patients with Cutaneous T-Cell Lymphoma (CTCL)miRagen Announces Internal Review of Preliminary Topline Data for the Phase 2 SOLAR Clinical Trial of Cobomarsen in Patients with Cutaneous T-Cell Lymphoma (CTCL)
finance.yahoo.com - October 17 at 9:16 AM
Mid-Day Market Update: Crude Oil Rises Over 3%; Miragen Therapeutics Shares SlideMid-Day Market Update: Crude Oil Rises Over 3%; Miragen Therapeutics Shares Slide
benzinga.com - October 6 at 6:57 PM
MiRagens cobomarsen short of the mark in mid-stage blood cancer studyMiRagen's cobomarsen short of the mark in mid-stage blood cancer study
seekingalpha.com - October 5 at 6:50 PM
miRagen names new CEO; to review portfoliomiRagen names new CEO; to review portfolio
seekingalpha.com - September 14 at 6:05 PM
miRagen Announces Leadership Transition and Review of Strategic AlternativesmiRagen Announces Leadership Transition and Review of Strategic Alternatives
finance.yahoo.com - September 14 at 6:05 PM
How Should Investors React To Miragen Therapeutics (NASDAQ:MGEN) CEO Pay?How Should Investors React To Miragen Therapeutics' (NASDAQ:MGEN) CEO Pay?
finance.yahoo.com - August 24 at 3:39 PM
How Should Investors React To Miragen Therapeutics' (NASDAQ:MGEN) CEO Pay?How Should Investors React To Miragen Therapeutics' (NASDAQ:MGEN) CEO Pay?
finance.yahoo.com - August 24 at 3:39 PM
miRagen Announces Results of Meeting With FDA Regarding the Design of Pivotal Trial for Cobomarsen in ATLLmiRagen Announces Results of Meeting With FDA Regarding the Design of Pivotal Trial for Cobomarsen in ATLL
finance.yahoo.com - August 20 at 8:10 PM
miRagen Therapeutics (MGEN) CEO Bill Marshall on Q2 2020 Results - Earnings Call TranscriptmiRagen Therapeutics' (MGEN) CEO Bill Marshall on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 5 at 11:22 PM
Signal Genetics, Inc. (MGEN) Reports Q2 Loss, Misses Revenue EstimatesSignal Genetics, Inc. (MGEN) Reports Q2 Loss, Misses Revenue Estimates
finance.yahoo.com - August 5 at 11:22 PM
Miragen Therapeutics EPS beats by $0.05, misses on revenueMiragen Therapeutics EPS beats by $0.05, misses on revenue
seekingalpha.com - August 5 at 6:21 PM
miRagen Reports Second Quarter 2020 Financial Results and Provides Business UpdatesmiRagen Reports Second Quarter 2020 Financial Results and Provides Business Updates
finance.yahoo.com - August 5 at 6:21 PM
miRagen to Present at the 2020 Wedbush PacGrow Healthcare Virtual ConferencemiRagen to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference
finance.yahoo.com - August 4 at 10:14 AM
Will Signal Genetics, Inc. (MGEN) Report Negative Earnings Next Week? What You Should KnowWill Signal Genetics, Inc. (MGEN) Report Negative Earnings Next Week? What You Should Know
finance.yahoo.com - July 29 at 1:32 PM
miRagen, Investigators from Goethe University and University Hospital Frankfurt and Servier Publish MRG-110 Phase 1 Pharmacodynamic Biomarker Data  in Nucleic Acid TherapeuticsmiRagen, Investigators from Goethe University and University Hospital Frankfurt and Servier Publish MRG-110 Phase 1 Pharmacodynamic Biomarker Data in Nucleic Acid Therapeutics
finance.yahoo.com - July 28 at 12:30 PM
miRagen Therapeutics up 39% on Orphan Drug tag for Cobomarsen in blood cancermiRagen Therapeutics up 39% on Orphan Drug tag for Cobomarsen in blood cancer
seekingalpha.com - July 23 at 5:41 PM
Cobomarsen Receives Orphan Drug Designation From the U.S. FDA for the Treatment of T-cell LymphomaCobomarsen Receives Orphan Drug Designation From the U.S. FDA for the Treatment of T-cell Lymphoma
finance.yahoo.com - July 23 at 5:41 PM
miRagen to Report Second Quarter 2020 Financial Results on August 5, 2020miRagen to Report Second Quarter 2020 Financial Results on August 5, 2020
finance.yahoo.com - July 22 at 10:12 AM
miRagen Therapeutics regains Nasdaq compliancemiRagen Therapeutics regains Nasdaq compliance
seekingalpha.com - July 2 at 7:08 PM
miRagen Regains Compliance With Nasdaq Listing RequirementsmiRagen Regains Compliance With Nasdaq Listing Requirements
finance.yahoo.com - July 2 at 7:08 PM
The Daily Biotech Pulse: Sanofi Expedites COVID-19 Vaccine Timeline, Apyx Cleared For Market Expansion, Miragens Positive ReadoutThe Daily Biotech Pulse: Sanofi Expedites COVID-19 Vaccine Timeline, Apyx Cleared For Market Expansion, Miragen's Positive Readout
finance.yahoo.com - June 24 at 2:38 PM
The Daily Biotech Pulse: Sanofi Expedites COVID-19 Vaccine Timeline, Apyx Cleared For Market Expansion, Miragen's Positive ReadoutThe Daily Biotech Pulse: Sanofi Expedites COVID-19 Vaccine Timeline, Apyx Cleared For Market Expansion, Miragen's Positive Readout
finance.yahoo.com - June 23 at 2:19 PM
miRagen Announces Encouraging Preclinical Safety and Efficacy Data for its Next-generation miR-29 Replacement Product Candidate Intended for the Treatment of Idiopathic Pulmonary FibrosismiRagen Announces Encouraging Preclinical Safety and Efficacy Data for its Next-generation miR-29 Replacement Product Candidate Intended for the Treatment of Idiopathic Pulmonary Fibrosis
finance.yahoo.com - June 22 at 7:06 PM
New operating chief at miRagen TherapeuticsNew operating chief at miRagen Therapeutics
seekingalpha.com - June 18 at 5:42 PM
miRagen Strengthens Leadership Team with Appointment of Lee Rauch as Chief Operating OfficermiRagen Strengthens Leadership Team with Appointment of Lee Rauch as Chief Operating Officer
finance.yahoo.com - June 18 at 5:42 PM
Company News for Jun 18, 2020Company News for Jun 18, 2020
finance.yahoo.com - June 18 at 12:42 PM
Thinking about buying stock in Energous Corp, Miragen Therapeutics, Hertz, Kopin Corp, or MGM Resorts?Thinking about buying stock in Energous Corp, Miragen Therapeutics, Hertz, Kopin Corp, or MGM Resorts?
www.benzinga.com - June 17 at 9:56 AM
MiRagen to host KOL event on ideopathic pulmonary fibrosis June 23MiRagen to host KOL event on ideopathic pulmonary fibrosis June 23
seekingalpha.com - June 16 at 5:50 PM
miRagen to Host a Key Opinion Leader Call on Idiopathic Pulmonary Fibrosis on Tuesday, June 23rdmiRagen to Host a Key Opinion Leader Call on Idiopathic Pulmonary Fibrosis on Tuesday, June 23rd
finance.yahoo.com - June 16 at 5:50 PM
Hedge Funds Aren’t Crazy About Miragen Therapeutics (MGEN)Hedge Funds Aren’t Crazy About Miragen Therapeutics (MGEN)
finance.yahoo.com - June 4 at 11:52 PM
Miragen Therapeutics (MGEN) Presents At Jefferies Healthcare Conference - SlideshowMiragen Therapeutics (MGEN) Presents At Jefferies Healthcare Conference - Slideshow
seekingalpha.com - June 3 at 7:02 PM
miRagen to Present at the Jefferies 2020 Virtual Global Healthcare ConferencemiRagen to Present at the Jefferies 2020 Virtual Global Healthcare Conference
finance.yahoo.com - May 26 at 8:20 AM
Did Changing Sentiment Drive Miragen Therapeutics' (NASDAQ:MGEN) Share Price Down A Painful 94%?Did Changing Sentiment Drive Miragen Therapeutics' (NASDAQ:MGEN) Share Price Down A Painful 94%?
finance.yahoo.com - May 12 at 4:21 PM
Miragen Therapeutics, Inc. (MGEN) CEO Bill Marshall on Q1 2020 Results - Earnings Call TranscriptMiragen Therapeutics, Inc. (MGEN) CEO Bill Marshall on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 10 at 3:35 AM
Miragen Therapeutics EPS beats by $0.03, beats on revenueMiragen Therapeutics EPS beats by $0.03, beats on revenue
seekingalpha.com - May 7 at 9:16 PM
miRagen Reports First Quarter 2020 Financial Results and Provides Corporate UpdatemiRagen Reports First Quarter 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - May 7 at 4:15 PM
BRIEF-Miragen Therapeutics Inc - On April 23 Received $1.7 Million Loan Funding From Paycheck Protection ProgramBRIEF-Miragen Therapeutics Inc - On April 23 Received $1.7 Million Loan Funding From Paycheck Protection Program
www.reuters.com - April 28 at 5:00 PM
This page was last updated on 3/5/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.